1014 related articles for article (PubMed ID: 21851551)
1. Significance of histological prostatitis in patients with urinary retention and underlying benign prostatic hyperplasia or adenocarcinoma of the prostate.
van Vuuren SP; Heyns CF; Zarrabi AD
BJU Int; 2012 Apr; 109(8):1194-7. PubMed ID: 21851551
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of histological prostatitis in men with benign prostatic hyperplasia or adenocarcinoma of the prostate presenting without urinary retention.
Edlin RS; Heyns CF; Van Vuuren SP; Zarrabi AD
S Afr J Surg; 2012 Nov; 50(4):127-30. PubMed ID: 23217554
[TBL] [Abstract][Full Text] [Related]
3. Calculated fast-growing benign prostatic hyperplasia--a risk factor for developing clinical prostate cancer.
Hammarsten J; Högstedt B
Scand J Urol Nephrol; 2002; 36(5):330-8. PubMed ID: 12487736
[TBL] [Abstract][Full Text] [Related]
4. [Influence of histological prostatitis on the clinical features of benign prostatic hyperplasia and prostate cancer].
Zhang F; Si-Mu-Jiang-Abula A; Zhang LD
Zhonghua Nan Ke Xue; 2014 Apr; 20(4):354-8. PubMed ID: 24873164
[TBL] [Abstract][Full Text] [Related]
5. Comparison of prostate cancer gene 3 score, prostate health index and percentage free prostate-specific antigen for differentiating histological inflammation from prostate cancer and other non-neoplastic alterations of the prostate at initial biopsy.
De Luca S; Passera R; Bollito E; Manfredi M; Scarpa RM; Sottile A; Randone DF; Porpiglia F
Anticancer Res; 2014 Dec; 34(12):7159-65. PubMed ID: 25503144
[TBL] [Abstract][Full Text] [Related]
6. IGF-II serum levels increase discrimination between benign prostatic hyperplasia and prostate cancer and improve the predictive value of PSA in clinical staging.
Trojan L; Bode C; Weiss C; Mayer D; Grobholz R; Alken P; Michel MS
Eur Urol; 2006 Feb; 49(2):286-92; discussion 292. PubMed ID: 16386354
[TBL] [Abstract][Full Text] [Related]
7. Effect of NIH-IV prostatitis on free and free-to-total PSA.
Stancik I; Lüftenegger W; Klimpfinger M; Müller MM; Hoeltl W
Eur Urol; 2004 Dec; 46(6):760-4. PubMed ID: 15548444
[TBL] [Abstract][Full Text] [Related]
8. [Clinical analysis of benign prostate hyperplasia with prostatitis].
Long Z; He L; Zhong K; Zhang Y; Yue D
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2010 Apr; 35(4):381-5. PubMed ID: 20448364
[TBL] [Abstract][Full Text] [Related]
9. Bladder catheterization and a plasma prostate-specific antigen in patients with benign prostatic hyperplasia and complete urine retention.
Dutkiewicz S; Stepień K; Witeska A
Mater Med Pol; 1995; 27(2):71-3. PubMed ID: 8935194
[TBL] [Abstract][Full Text] [Related]
10. The influence of prostate volume on the ratio of free to total prostate specific antigen in serum of patients with prostate carcinoma and benign prostate hyperplasia.
Stephan C; Lein M; Jung K; Schnorr D; Loening SA
Cancer; 1997 Jan; 79(1):104-9. PubMed ID: 8988733
[TBL] [Abstract][Full Text] [Related]
11. Role of AgNOR count and its correlation with serum PSA levels in prostatic lesions.
Goel T; Garg S
Urol Int; 2009; 82(3):286-90. PubMed ID: 19440015
[TBL] [Abstract][Full Text] [Related]
12. [Changes of serum total PSA and free PSA in patients with prostate carcinoma and benign prostate hyperplasia].
Gao ZW; Liu G; Sheng BW
Ai Zheng; 2004 Jun; 23(6):701-3. PubMed ID: 15191675
[TBL] [Abstract][Full Text] [Related]
13. [Histological changes of the prostate and acute urinary retention in patients with benign prostatic hyperplasia].
Bao QB; He GH; Liu GY; Zhang CG; Yang C
Zhonghua Nan Ke Xue; 2013 Sep; 19(9):811-4. PubMed ID: 24386860
[TBL] [Abstract][Full Text] [Related]
14. [Changes in the levels of prostate-specific antigen and its molecular forms with alpha 1-antichymotrypsin in patients with benign prostatic hyperplasia].
Grigor'ev ME; Mazo EB; Chekhonin VP
Urol Nefrol (Mosk); 1998; (4):33-7. PubMed ID: 9727319
[TBL] [Abstract][Full Text] [Related]
15. Relationship of chronic histologic prostatic inflammation in biopsy specimens with serum isoform [-2]proPSA (p2PSA), %p2PSA, and prostate health index in men with a total prostate-specific antigen of 4-10 ng/ml and normal digital rectal examination.
Lazzeri M; Abrate A; Lughezzani G; Gadda GM; Freschi M; Mistretta F; Lista G; Fossati N; Larcher A; Kinzikeeva E; Buffi N; Dell'Acqua V; Bini V; Montorsi F; Guazzoni G
Urology; 2014 Mar; 83(3):606-12. PubMed ID: 24315305
[TBL] [Abstract][Full Text] [Related]
16. [Prostate-specific antigen as a prostatic tumor marker. Analysis of results in 206 patients].
Rodríguez Duarte C
Arch Esp Urol; 1991; 44(6):697-700. PubMed ID: 1722962
[TBL] [Abstract][Full Text] [Related]
17. Ratio of free-to-total prostate specific antigen in serum cannot distinguish patients with prostate cancer from those with chronic inflammation of the prostate.
Jung K; Meyer A; Lein M; Rudolph B; Schnorr D; Loening SA
J Urol; 1998 May; 159(5):1595-8. PubMed ID: 9554361
[TBL] [Abstract][Full Text] [Related]
18. Clinical significance of high-grade prostatic intraepithelial neoplasia in transurethral resection specimens.
Pacelli A; Bostwick DG
Urology; 1997 Sep; 50(3):355-9. PubMed ID: 9301697
[TBL] [Abstract][Full Text] [Related]
19. How do patients with familial benign prostatic hyperplasia differ clinically from those with sporadic benign prostatic hyperplasia?
Oztekin CV; Oztürk B; Taş M; Uğurlu O; Cetinkaya M
Urol Int; 2006; 76(4):332-4. PubMed ID: 16679835
[TBL] [Abstract][Full Text] [Related]
20. [Correlation of histological prostatitis with PSA, prostate volume, PSAD, IPSS, Qmax and PVR in BPH patients].
Zhang HT; Xu Y; Chang JW; Zhang ZH; Liu RL; Ma BJ
Zhonghua Nan Ke Xue; 2012 Mar; 18(3):208-11. PubMed ID: 22474983
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
